Phenotypic and Genotypic Characterization of Patients With Dysmetabolism in Greenland
Recruiting
N/A
Interventional Study
Diabetes Mellitus, Type 2
Obesity, Morbid
Obstructive Sleep Apnea
MODY
Diabetic Retinopathy
Diabetic Neuropathies
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 1,000 (estimated)
- Sponsor
- Steno Diabetes Center Greenland · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to perform a detailed description of the feno- and genotype of people living with type 2 diabetes and severe obesity who are linked to care at Steno Diabetes Center Greenland.
The main questions it aims to answer are:
* Are monogenetic diabetes variants associated with the same risk of developing late diabetic complications as other types of diabetes?
* Can gen…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Type 2 diabetes and/or morbid obesity (BMI \>40)
* Over 18 years old
Exclusion Criteria:
* Does not speak either English, Danish or Greenlandic
Contacts